Summary
The microvasculature of the central nervous system (CNS) is characterized by tight junctions between the endothelial cells and, thus, behaves as a continuous lipid bilayer that prevents the passage of polar and lipid-insoluble substances such as peptides. Highly active enzymes expressed in the morphological compontents of the microcirculation also represent a metabolic component that contributes to the homeostatic balance of the CNS. Peptides generally cannot enter the brain and spinal cord from the circulating blood because they are highly polar and lipid insoluble, metabolically unstable, and active transport systems only exist for very few of them in this membraneous barrier separating the systemic circulation from the interstitital fluid of the CNS. This blood-brain barrier is, therefore, the major obstacle to peptide-based drugs that are potentially useful for combating diseases affecting the brain and spinal cord. This review discusses and critically evaluates invasive, chemical-enzymatic (prodrug and chemical delivery/targeting system) and biological carrier-based approaches to overcome the blood-brain barrier for these highly active and versatile molecules that are very attractive as a future generation of neuropharmaceuticals.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Abbreviations
- BBB:
-
blood-brain barrier
- CDS:
-
chemical delivery system
- CNS:
-
central nervous system
- CSF:
-
cerebrospinal fluid
- CVO:
-
circumventricular organ
- DPDPE:
-
[D-Pen2, D-Pen5]enkephalin
- EC:
-
enzyme commission
- GLUT:
-
glucose transporter
- i.c.v.:
-
intracerebroventricular
- IGF:
-
insulin-like growth factor
- IgG:
-
immunoglobulin
- i.t.:
-
intratechal
- i.v.:
-
intravenous
- Lpf:
-
lipophilic functional group
- MAb:
-
monoclonal antibody
- NGF:
-
nerve-growth factor
- NAD+ :
-
nicotinamide adenine dinucleotide (phosphate)
- NAD(P)H:
-
nicotinamide adenine dinucleotide (phosphate), reduced form
- OX26 (TfRMAb):
-
murine monoclonal antibody toothe rat transferrin receptor
- Pgp:
-
P-glycoprotein
- RMP:
-
receptor-mediated permeabilizer
- S:
-
spacer amino acid residue(s)
- T:
-
redox targetor
- T+ :
-
redox targetor, oxidized
- TRH:
-
thryrotropin-releasing hormone
- VIPa:
-
vasoactive intestinal peptide analogue
References
P. Ehrlich: Das Sauerstoff-BedĂĽrfniss des Organismus: Eine farbenanalytische Studie, Hirschwald, Berlin 1885.
M. Brightman, in: M.W.B. Bradbury (ed.): Physiology and Pharmacology of the Blood-Brain Barrier, Springer-Verlag, Berlin 1992, p. 1.
T.S. Reese and M.J. Karnovsky: J. Cell. Biol. 34, 207 (1967).
C. Crone, in: B.K. Siesjo and S.C. Sorensen (eds.): Ion Homeostasis of the Brain, Munksgaard, Copenhagen 1971, p. 52.
H. Davson K. Welch and M.B. Segal: The Physiology and Pathophysiology of the Cerebrospinal Fluid. Churchill Livingstone, Edinburgh (UK) 1987, p. 105.
D.J. Begley: J. Pharm. Pharmacol. 48, 136 (1996).
T. Yamaguchi, M. Yamaguchi and A. Lajtha: J. Neurol. Sci. 10, 323 (1970).
B.V. Zlokovic, J.B. Mackic, B. Djuricic and H. Dawson: J. Neurochem. 53, 1333 (1989).
B.V. Zlokovic, V. Susic, H. Davson, D.J. Begley, R.M. Jankov, D.M. Mitrovic and M.N. Lipovac: Peptides 10, 249 (1989).
B.V. Zlokovic: Pharm. Res. 12, 1395 (1995).
W.A. Banks and A.J. Kastin: Pharmacol. Biochem. Behav. 21, 943 (1984).
T. Terasaki, K. Hirai, H. Sato, Y. Kang and A. Tsuji: J. Pharmacol. Exp. Ther. 251, 351 (1989).
W.M. Pardridge: Peptide Drug Delivery to the Brain, Raven Press, New York 1990, p. 189.
T. Terasaki, Y. Deguchi, H. Sato, K. Hirai and A. Tsuji: Pharm. Res. 8, 815 (1991).
P.M. Friden, in: W.M. Pardridge (ed.): The Blood-Brain Barrier: Cellular and Molecular Biology, Raven Press, New York 1993, p. 229.
W.M. Pardridge: Endocrine Rev. 7, 314 (1986).
C. Cordon-Cardo, J.P. O’Brien, D. Casals, L. Rittman-Grauer, J.L. Beideler, M.R. Melamed and J.R. Bertino: Proc. Natl. Acad. Sci. USA 86, 695 (1989).
T. Tatsut, M. Naito, T. Oh-hara, I. Sugawara and T. Tsuruo: J. Biol. Chem. 28, 20383 (1992).
A. Tsuji, I. Tamai, A. Sakata, Y. Tenda and T. Terasaki: Biochem. Pharmacol. 46, 1096 (1993).
A. Tsuji, in: V.H.L. Lee, M. Hashida and Y. Mizushima: Trends and Future Perspectives in Peptide and Protein Drug Delivery, Harwood Academic Publishers, Chur (Switzerland) 1995, p. 153.
W.M. Pardridge: Peptide Drug Delivery to the Brain, Raven Press, New York, 1991.
R.D. Egleton and T.P. Davis: Peptides 18, 1431 (1997).
A. Bertler, B. Falck, C. Owman and E. Rosengrenn: Pharmacol. Rev. 18, 369 (1966).
H.H. Bausback and P.E. Ward: Biochem. Pharmacol. 37, 2973 (1988).
T. Tatsuta, M. Naito, T. Oh-hara, I. Sugawara and T. Tsuruo: J. Biol. Chem. 28, 20383 (1992).
E.A. Brownson, T.J. Abbruscato, T.J. Gillespie, V.J. Hruby and T.P. Davis: J. Pharmaco. Exp. Ther. 270, 657 (1994).
J. Brownlees and C.H. Williams: J. Neurochem. 60, 793 (1993).
A. Fray, B. Meckelein, H. Weiler-Guttler, B. Meckel, R. Flach and H.G. Gassen: Eur. J. Biochem. 202, 421 (1991).
W. Risau, A. Dingier, U. Albrecht, M.-P. Dehouck and R. Cecchelli: J. Neurochem. 58, 667 (1992).
D.P. Healy and S. Wilk: Brain. Res. 472, 165 (1993).
J. Kunz, D. Krause, M. Kremer and R. Dermietzel: J. Neurochem. 62, 2375 (1994).
B. Zlokovic, D. Begley, M. Segal, H. Dawson, L. Rakic, M. Lipovac and D.M. Mitrovic, in: L. Rakic, D.J. Begley, H. Davson and B. Zlokovic (eds.): Peptide and Amino Acid Transport Mechanisms in the Central Nervous System, MacMillan Press, London 1988, p. 3.
A. Samii, U. Bickel, U. Stroth and W.M. Pardridge: Am. J. Physiol. 267, E124 (1994).
C.T. Dooley, N.N. Chung, B.C. Wilkes, P.W. Schiller, G.W. Pasternak and R.A. Houghten: Science 266, 2019 (1994)
P.M. Carvey, T.J. Maag and D. Lin: Methods Neurosci. 21, 214 (1994).
J.T. Caroscio, J. Zawodniak, V. Takai, A. Dhapiro, S. Blaustein, M.N. Mulvihill, S. P. Loucas, M. Gudelsblatt, D. Rube and M.D. Yahr: Neurology 36, 141 (1986).
T.L. Munsat, J. Taft and I.M.D. Jackson: Neurology 37, 597 (1987).
T.L. Munsat, J. Taft and I.M.D. Jackson: Neurology 42, 1049 (1992).
E. Passaro, Jr., H. Debas, W. Oldendorf and T. Yamada: Brain Res. 241, 335 (1982)
L.M. Maness, W.A. Banks, J.E. Zadina and A.J. Kastin: Peptides 17, 247 (1995).
D.A. Durham, W.A. Banks and A.J Kastin: Neuroendocrinology 53, 447 (1991).
D.G. Poplack, A.W. Bleyer and M.E. Horowitz, in: J.H. Wood (ed.): Neurobiology of Cerebrospinal Fluid, Plenum Press, New York 1980, p. 561.
A.J. Domb and I. Ringel: Methods Neurosci. 21, 169 (1994).
J. Brem, A.J. Domb, D. Lenartz, C. Dureza, A. Olivi and J.I. Epstein: J. Controlled Release 19, 325 (1992).
C.E. Krewson and W.M. Saltzman, in: V.H.L. Lee, M. Hashida and Y. Mizushima (eds.): Trends and Future Perspectives in Peptide and Protein Drug Delivery, Harwood Academic Publishers, Chur (Switzerland) 1995, p. 273.
E.M. Powell, M.R. Sobarzo and W.M. Saltzman: Brain Res. 515, 309 (1990).
A. Mendez, P.J. Camarata, R. Suryanarayanan and T.J. Ebner: Methods Neurosci. 21, 150 (1994).
A. Bonetti and S. Kim: Cancer Chemother. Pharmacol. 33, 258 (1993).
M.J. Lysaght, B. Frydel, F. Gentile, D. Emerich and S. Winn: J. Cell. Biochem. 196 (1994).
E.A. Neuwelt and R.A. Kroll: Methods Neurosci. 21, 52 (1994).
E.A. Neuwelt, H.D. Specht, P.A. Barnett, S.A. Dahlborg, A. Miley, S.M. Larson, P. Brown, K.F. Eckerman, K.E. Hellstrom and I. Hellstrom: Neurosurgery 20, 885 (1987).
E.A. Neuwelt, R. Weissleder, G. Nilaver, R.A. Kroll, S. Roman-Goldstein, J. Szumowski, M.A. Pagel, R.S. Jones, L.G. Remsen, C. McCormick, E.M. Shannon and L.L. Muldoon: Neurosurgery 34, 777 (1994).
M.K. Gumerlock and E.A. Neuwelt, in: M.W.B. Bradbury (ed.): Physiology and Pharmacology of the Blood-Brain Barrier, Springer, Berlin 1992, p. 525.
J.J. Raymond, D.M. Robertson and H.-B. Dinsdale: Can. J. Neurol. Sci. 13, 214 (1986).
E. Sanovich, R.T. Bartus, P.M. Friden, R.L. Dean, H.Q. Lee and M.W. Brightman: Brain Res. 705, 125 (1995).
J. Kreuter, R.N. Alyautdin, D.A. Kharkevich and A.A. Ivanov: Brain Res. 674, 171 (1995).
R.N. Alyautdin, D. Gothier, V. Petrov, D. Kharkevich and J. Kreuter: Eur. J. Pharm. Biopharm. 41, 44 (1995).
U. Schröder and B.A. Sabel: Brain Res. 710, 121 (1996).
H.M. Patel: Biochem. Soc. Trans. 12, 333 (1984)
W.M. Pardridge, D. Triguero, J. Yang and P.A. Cancilla: Pharmacol. Exp. Ther. 253, 884 (1990).
M. Abraham, H.S. Chada and R.C. Mitchell: J. Pharm. Sci. 83, 1257 (1994).
S.A. Thomas, T.J. Abbruscato, V.S. Hau, T.J. Gillespie, J. Zsigo, V.J. Hruby and T.P. Davis: J. Pharm. Exp. Ther. 280, 1235 (1997).
S.J. Weber, D.L. Greene, S.D. Sharma, H.I. Yamamura, T.H. Kramer, T.F. Burks, V.J. Hruby, L.B. Hersch and T.P. Davis: J. Pharm. Exp. Ther. 259, 1109 (1991).
P.L. Hoffman, R. Walter and M. Bulat: Brain Res. 122, 87 (1977).
H. Bundgaard: Design of Prodrugs, Elsevier, Amsterdam 1985, p. 1.
H. Bundgaard: J. Controlled Release 21, 63 (1992).
H. Bundgaard: Adv. Drug Deliv. Rev. 8, 1 (1992).
J. Moss, in: M.D. Taylor and G.L. Amidon (eds.): Peptide-Based Drug Design, American Chemical Society, Washington, DC 1995, p. 421.
D. Brewster, in: E.C. Griffiths and G.W. Bennett (eds.): Thyrotropin-Releasing Hormone, Raven Press, New York 1983, p. 109.
S. Muranishi S, A. Sakai, Y. Yamada, M. Murakami, K. Takada and Y. Kiso: Pharm. Res. 5, 649 (1991).
H. Bundgaard and J. Moss: Pharm. Res. 7, 885 (1990).
N. Tsuzuki, T. Hama, T. Hibi, R. Konishi, S. Futaki and K. Kitagawa: Biochem. Pharmacol. 41, R5 (1991).
K. Kitagawa, N. Mizobuchi, T. Hama, T. Hibi, R. Konishi and S. Futaki: Chem. Pharm. Bull. 45, 1782 (1997).
D. Greene, V.S. Hau, T.J. Abbruscato, H. Bartosz, A. Misicka, A. W. Lipowski, S. Horn, T. J. Gilespie, V. J. Hruby and T. P. Davis: J. Pharmacol. Exp. Ther. 277, 1366 (1996).
A. Misicka, I. Maszczynska, A.W. Lipkowski, D. Stropova, H.I. Yamamura and V.J. Hruby: Life Sci. 58, 905 (1996).
D. Patel, B.D. McKinley, T.P. Davis, F. Porreca, H.I. Yamamura and V.J. Hruby: Bioconj. Chem. 8, 434 (1997).
N. Bodor and L. Prokai, in: M.D. Taylor and G.L. Amidon (eds.): Peptide-Based Drug Design, American Chemical Society, Washington, DC 1995, p. 317.
N. Bodor and M.E. Brewster, in: R.L. Juliano (ed.): Handbook of Experimental Pharmacology, Vol. 100, Targeted Drug Delivery, Springer-Verlag, Berlin 1991, p. 231.
N. Bodor, L. Prokai, W.-M. Wu, H. Farag, S. Jonnalagadda, T. Kawamura and J. Simpkins: Science 257, 1698 (1992).
N. Bodor and L. Prokai, in: R.S. Hodges J.A. Smith (eds.): Peptides: Chemistry, Structure and Biology, ESCOM Science Publishers, Leiden (The Netherlands) 1994, p. 830–833.
J.W. Simpkins, X. Ouyang, L. Prokai and N. Bodor: Neuroprotocols: A Companion to Methods in Neurosciences 4, 225 (1994).
K. Prokai-Tatrai, L. Prokai and N. Bodor: J. Med. Chem. 39, 4775 (1996).
L. Prokai, X. Ouyang, W.-M. Wu and N. Bodor: J. Am. Chem. Soc. 116, 2643 (1994).
L. Prokai, K. Prokai-Tatrai, W.-M. Wu, J. Wu, X. Ouyang, H.-S. Kim, A. Zharikova, J. Simpkins, N. Bodor, in: J.P. Tarn and P.T.P. Kaumaya (eds.): Peptides: Chemistry, Structure and Biology, Kluver Academic, Dordrecht (The Netherlands) 1997, in press.
H.-S. Kim: Ph.D. Thesis, University of Florida, Gainesville, FL, 1997.
B.V. Zlokovic, S. Hyman, J.G. McComb, M.N. Lipovac, G. Tang and H. Dawson: Biochem. Biophys. Acta 1025, 191 (1990).
R. Polt, F. Porreca, L.Z. SzabĂł, E.J. Bilsky, P. Davis, T.J. Abbruscato, T.P. Davis, R. Horvath, H.I. Yamamura and V.J. Hruby: Proc. Natl. Acad. Sci. USA 91, 7114 (1994).
Vargadefterdavrovic, S. Horvat, N.N. Chung and P.W. Schiller: Int. J. Pept. Prot. Res. 39, 12 (1992).
S. Horvat, J. Horvat, L. Vargadefterdavrovic, K. Pavelic, N.N. Chung and P.W. Schiller: Int. J. Pept. Prot. Res. 41, 399 (1993).
W.M. Pardridge: Adv. Drug Deliv. Rev. 15, 109 (1995).
P.M. Friden: J. Controlled Release 46, 117 (1997).
M. Fukuta, H. Okada, S. Iinuma, S. Yanai and H. Toguchi: Pharm. Res. 11, 1681 (1994).
F. Ito, S. Ito, S. and N. Shimizu: Mol. Cell Endocrinol. 36, 165 (1984).
V. Raso and M. Basala: J. Biol. Chem. 259, 1143 (1984).
A.K. Kumagai, J. Eisenberg and W.M. Pardridge: J. Biol. Chem. 262, 15214 (1987).
W.M. Pardridge, D. Triguero and J.L. Buciak: Endocrinology 126, 977 (1990).
Y.-S. Kang and W.M. Pardridge: J. Pharmacol. Exp. Ther. 269, 344 (1994).
R.D. Broadwell, B J. Baker, W.A. Banks, P.M. Friden, M. Moran, C. Oliver and J.C. Villegas: Methods Neurosci. 21, (1994).
W.M. Pardridge, Y.-S. Kang, J.L. Buciak and J. Yang: Pharm. Res. 6, 807 (1995).
P.M. Friden: Neurosurgery 35, 294 (1994).
P.M. Frieden, L.R. Walus, P. Watson, S.R. Doctorow, J.W. Kozarich, C. Bäckman, H. Bergman, B. Hoffer, F. Bloom and A.-C. Granholm: Science 259, 373 (1993).
A.-C. Granholm, C. Bäckman, F. Bloom, T. Ebendal, G. Gerhardt, B. Hoffer, L. Mackerlova, L. Olson, S. Soderstrom, L.R. Walus and P.M. Friden: J. Pharmacol. Exp. Ther. 268, 448 (1994).
C. Bäckman, P.T. Biddle, T. Ebendal, P.M. Friden, G.A. Gerhardt, M.A. Henry, L. Mackerlova, S. Söderström, I. Stromberg, L. Walus, B.J. Hoffer and A.-C. Granholm: Exp. Neurol. 132, 1 (1995).
J.H. Kordower, V. Charles, R. Bayer, R.T. Bartus, S. Putney, L.R. Walus and P.M. Friden: Proc. Natl. Acad. Sci. USA 91, 9077 (1994).
T. Yoshikawa and W.M. Pardridge: J. Pharmacol. Exp. Ther. 263, 897 (1992).
U. Bickel, T. Yoshikawa, E.M. Landaw, K.E Faull and W.M. Pardridge: Proc. Natl. Acad. Sci. USA 90, 2618 (1993).
N.M. Green: Methods Enzymol. 184, 51 (1990).
U. Bickel, Y.-S. Kang and W.M. Pardridge: Bioconj. Chem. 6, 211 (1995).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Basel AG
About this chapter
Cite this chapter
Prokai, L. (1998). Peptide drug delivery into the central nervous system. In: Jucker, E. (eds) Progress in Drug Research. Progress in Drug Research, vol 51. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8845-5_3
Download citation
DOI: https://doi.org/10.1007/978-3-0348-8845-5_3
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-9798-3
Online ISBN: 978-3-0348-8845-5
eBook Packages: Springer Book Archive